2023 - Research.com Immunology in Canada Leader Award
2022 - Research.com Immunology in Canada Leader Award
2002 - Fellow of the Royal Society of Canada Academy of Science
Member of the Association of American Physicians
His primary areas of study are Heparin, Heparin-induced thrombocytopenia, Platelet, Internal medicine and Immunology. His Heparin study integrates concerns from other disciplines, such as Anticoagulant, Pharmacology and Platelet activation. His Heparin-induced thrombocytopenia study combines topics from a wide range of disciplines, such as Anesthesia and Argatroban, Lepirudin, Danaparoid.
The concepts of his Platelet study are interwoven with issues in Monoclonal antibody, Blood coagulation test, Fc receptor and Neonatal Thrombocytopenia. His Internal medicine research includes elements of Gastroenterology, Surgery and Cardiology. His work on Antibody, Immunoglobulin G and Thrombocytopenic purpura as part of his general Immunology study is frequently connected to Diagnostic test, thereby bridging the divide between different branches of science.
His primary scientific interests are in Platelet, Immunology, Internal medicine, Antibody and Heparin. John G. Kelton interconnects Molecular biology and Pharmacology in the investigation of issues within Platelet. His work in Internal medicine addresses issues such as Gastroenterology, which are connected to fields such as Adverse effect.
His work deals with themes such as Biochemistry, Antigen and Neonatal alloimmune thrombocytopenia, which intersect with Antibody. His research in Heparin intersects with topics in Anticoagulant and Thrombosis. His Heparin-induced thrombocytopenia study integrates concerns from other disciplines, such as Argatroban and Danaparoid.
John G. Kelton mainly focuses on Platelet, Immunology, Heparin-induced thrombocytopenia, Heparin and Platelet factor 4. His Platelet research is classified as research in Internal medicine. His study on Internal medicine is mostly dedicated to connecting different topics, such as Surgery.
His work on Rituximab and Immunoglobulin binding as part of general Immunology research is frequently linked to Thrombopoietin, Thrombopoiesis and Context, thereby connecting diverse disciplines of science. His studies in Heparin integrate themes in fields like Orthopedic surgery, Anti platelet, Proteolysis and Surrogate endpoint. His work carried out in the field of Platelet factor 4 brings together such families of science as Immunoassay, Antibody, Mutant and Immune system.
His primary areas of investigation include Immunology, Platelet, Immune thrombocytopenia, Internal medicine and Autoantibody. Many of his studies on Immunology involve topics that are commonly interrelated, such as Heparin. John G. Kelton studies Heparin, namely Heparin-induced thrombocytopenia.
His Platelet research is multidisciplinary, relying on both Disease and Diagnosis of exclusion. He has researched Immune thrombocytopenia in several fields, including MEDLINE and Confidence interval. His Internal medicine research incorporates elements of Gastroenterology and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
Theodore E. Warkentin;Mark N. Levine;Jack Hirsh;Peter Horsewood.
The New England Journal of Medicine (1995)
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
JN George;SH Woolf;GE Raskob;JS Wasser.
Blood (1996)
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.
Gail A. Rock;Kenneth H. Shumak;Noel A. Buskard;Victor S. Blanchette.
The New England Journal of Medicine (1991)
Temporal aspects of heparin-induced thrombocytopenia.
Theodore E. Warkentin;John G. Kelton.
The New England Journal of Medicine (2001)
A 14-year study of heparin-induced thrombocytopenia
Theodore E. Warkentin;John G. Kelton;John G. Kelton.
The American Journal of Medicine (1996)
A diagnostic test for heparin-induced thrombocytopenia
David Sheridan;Cedric Carter;John G. Kelton.
Blood (1986)
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
B. E. Lewis;D. E. Wallis;S. D. Berkowitz;W. H. Matthai.
Circulation (2001)
Impact of the patient population on the risk for heparin-induced thrombocytopenia
Theodore E. Warkentin;Jo-Ann I. Sheppard;Peter Horsewood;Patricia J. Simpson.
Blood (2000)
Systematic review : Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold;Francesco Dentali;Mark A. Crowther;Ralph M. Meyer.
Annals of Internal Medicine (2007)
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity : an explanation for the thrombotic complications of heparin-induced thrombocytopenia
Theodore E. Warkentin;Catherine P.M. Hayward;Lynn K. Boshkov;Aurelio V. Santos.
Blood (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
McMaster University
McMaster University
McMaster University
McMaster University
University of Waterloo
McMaster University
McMaster University
University of Toronto
McMaster University
McMaster University
The University of Texas at Austin
École Polytechnique Fédérale de Lausanne
Huazhong University of Science and Technology
Tel Aviv University
Radboud University Nijmegen
University of Wyoming
Iowa State University
National Institute for Space Research
National Institute of Technology Tiruchirappalli
Grenoble Alpes University
Université Paris Cité
National Institute of Allergy and Infectious Diseases
Aarhus University
Emory University
Thomas Jefferson University
Netherlands Institute for Space Research